Responses
Chronic obstructive pulmonary disease
Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial
Compose a Response to This Article
Other responses
No responses have been published for this article.